About ADC Biotechnology
ADC Biotechnology is a company based in Saint Asaph (United Kingdom) founded in 2010 was acquired by Sterling Pharma Solutions in April 2021.. ADC Biotechnology has raised $16.16 million across 7 funding rounds from investors including Development Bank of Wales, Downing and Maven Capital Partners. The company has 38 employees as of March 31, 2022. ADC Biotechnology offers products and services including Prediksi Macau and Live Draw Macau. ADC Biotechnology operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter Saint Asaph, United Kingdom
- Employees 38 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Adc Biotechnology Ltd
-
Annual Revenue
$2.11 M (USD)-2as on Apr 30, 2020
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.16 M (USD)
in 7 rounds
-
Latest Funding Round
-
Investors
Development Bank of Wales
& 10 more
-
Employee Count
38
as on Mar 31, 2022
-
Acquired by
Sterling Pharma Solutions
(Apr 07, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ADC Biotechnology
ADC Biotechnology offers a comprehensive portfolio of products and services, including Prediksi Macau and Live Draw Macau. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides forecasts for Macau lottery numbers
Delivers real-time lottery draw updates
Funding Insights of ADC Biotechnology
ADC Biotechnology has successfully raised a total of $16.16M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
- First Round First Round
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2020 | Amount | Series A - ADC Biotechnology | Valuation | Sterling Pharma Solutions |
|
| Nov, 2018 | Amount | Series A - ADC Biotechnology | Valuation | Maven Capital Partners , Seneca |
|
| Apr, 2018 | Amount | Series A - ADC Biotechnology | Valuation | Downing , BioScience Managers |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ADC Biotechnology
ADC Biotechnology has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Development Bank of Wales, Downing and Maven Capital Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Inheritance tax relief, funds, and bonds are provided across sectors.
|
Founded Year | Domain | Location | |
|
BioScience Managers is engaged in healthcare investment and innovation.
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for private equity investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ADC Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ADC Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Adc Biotechnology Comparisons
Competitors of ADC Biotechnology
ADC Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Adc Biotechnology
Frequently Asked Questions about ADC Biotechnology
When was ADC Biotechnology founded?
ADC Biotechnology was founded in 2010.
Where is ADC Biotechnology located?
ADC Biotechnology is headquartered in Saint Asaph, United Kingdom. It is registered at Saint Asaph, Denbighshire, United Kingdom.
Is ADC Biotechnology a funded company?
ADC Biotechnology is a funded company, having raised a total of $16.16M across 7 funding rounds to date. The company's 1st funding round was a Series A of $1.59M, raised on Sep 01, 2010.
How many employees does ADC Biotechnology have?
As of Mar 31, 2022, the latest employee count at ADC Biotechnology is 38.
What is the annual revenue of ADC Biotechnology?
Annual revenue of ADC Biotechnology is $2.11M as on Apr 30, 2020.
What does ADC Biotechnology do?
ADC Bio is developing antibody-drug conjugate (ADC). Its proprietary technology called Lock-Release involves conjugation of proteins that are immobilised on solid supports and delivers key product advantages from minimal aggregate formation to minimal residual free drug and enhanced yields. It also provides technical services including conjugation to a variety of toxin payloads, toxin-linker design and synthesis and supply of ADCs for proof of concept and toxicology testing.
Who are the top competitors of ADC Biotechnology?
ADC Biotechnology's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does ADC Biotechnology offer?
ADC Biotechnology offers Prediksi Macau and Live Draw Macau.
Who are ADC Biotechnology's investors?
ADC Biotechnology has 11 investors. Key investors include Development Bank of Wales, Downing, Maven Capital Partners, Sterling Pharma Solutions, and Welsh Government.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.